Market research
ITMR Itamar Medical Ltd
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 507M
- P/E ratio
- Not available
- Analyst target
- 30.75
- Dividend yield
- 0.0%
- Beta
- 0.54
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US4654371016
- Market cap
- 507M
- P/E ratio
- Not available
- Analyst target
- 30.75
- Dividend yield
- 0.0%
- Beta
- 0.54
About
About Itamar Medical Ltd
Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. As of December 16, 2021, Itamar Medical Ltd. operates as a subsidiary of ZOLL Medical Corporation.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ITMR discussion.
5 years, 4 months ago
Itamar Medical Ltd is currently in a long term uptrend where the price is trading 7.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
Itamar Medical Ltd's total revenue rose by 30.8% to $13M since the same quarter in the previous year.
Its net income has dropped by 194.3% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 37.4% to $-1M since the same quarter in the previous year.
Based on the above factors, Itamar Medical Ltd gets an overall score of 4/5.